1-6 of 6
Julia Arfi-Rouche
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Early Phase Clinical Trials for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jean-Marie Michot, MD, Valérie Camara-clayette, Audrey Detolle, Claude Chahine, MD, Julien Lazarovici, MD, Alina Danu, MD, Jacques Bosq, David Ghez, MD PhD, Peggy Dartigues-Cuillères, MD, Julia Arfi-Rouche, Rastilav Bahleda, Wassila Rahali, Andrea Varga, Capucine Baldini, Lambros Tselikas, Clélia Paume, Helene Lecourt, Sophie Cotteret, Veronique Vergé, Jean-Charles Soria, Christophe Massard, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4110.
https://doi.org/10.1182/blood-2018-99-110852
Published: 2018
Journal Articles

Feasibility and Benefit of Molecularly-Informed Enrollment into Personalized Therapies or Early Phase Trials for Patients with Relapsed or Refractory Multiple Myeloma

Tarek Assi, Jean-Marie Michot, MD, Toni Ibrahim, MD MSc, Fabien Le Bras, Karim Belhadj, Julien Lazarovici, MD, David Ghez, MD PhD, Julien Rossignol, MD PhD, Veronique Vergé, Julia Arfi-Rouche, Sophie Cotteret, Christophe Massard, Jean-Charles Soria, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2001.
https://doi.org/10.1182/blood-2018-99-111050
Published: 2018
Journal Articles

Non-Effectiveness of Using RICE Post RDHAP or RDHAP Post RICE after Failure of First Line Salvage Therapy in DLBCL Patients Who Are Eligible for ASCT

Tony Ibrahim, MD MSc, Tarek Assi, Julien Lazarovici, MD, Maxime Annereau, PharmD, David Ghez, MD PhD, Jean-Marie Michot, MD, Julia Arfi-Rouche, Julien Rossignol, MD PhD, Veronique Vergé, Jacques Bosq, Peggy Dartigues-Cuillères, MD, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4226.
https://doi.org/10.1182/blood-2018-99-117444
Published: 2018
Journal Articles

Crizotinib in Advanced ALK+ Anaplastic Large Cell Lymphoma in Children and Adults: Results of the Acs© Phase II Trial

Laurence Brugières, Roch Houot, MD PhD, Nathalie Cozic, Christelle De La Fouchardière, Franck Morschhauser, MD PhD, Pauline Brice, MD, Nina Arakelyan Laboure, Anne Auvrignon, Nathalie Aladjidi, MD, Brigitte Kolb, MD, Laurence Blanc, Anne Pagnier, Julia Arfi-Rouche, Anne Ségolène Cottereau, Céline AIT Oukhatar, Natalie Hoog Labouret, Gilles Vassal, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2831.
https://doi.org/10.1182/blood.V130.Suppl_1.2831.2831
Published: 2017
Journal Articles

Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma

Khalil Saleh, MD, Jean-Marie Michot, MD, Alina Danu, MD, Julien Lazarovici, MD, Nadine Khalifé-Saleh, MD, David Ghez, PhD MD, Claude Chahine, MD, Yolla Dakdouki, MD, Jonathan Fahri, Resident, Christophe Willekens, MD, Angela Boros, MD, Julia Arfi-Rouche, MD, Pierre Maroun, MD, Eric Deutsch, PhD MD, Vincent Ribrag, MD, Renaud Mazeron, MD
Journal: Blood
Blood (2016) 128 (22): 1784.
https://doi.org/10.1182/blood.V128.22.1784.1784
Published: 2016
Journal Articles

BEAM or BeEAM High-Dose Chemotherapy Followed By ASCT: A Single Center Comparative Analysis of Toxicity

Vincent Ribrag, MD, Khalil Saleh, MD, Alina Danu, MD, Serge Koscielny, Sylvain Pilorge, MD, Cristina castilla-Lorente, MD, David Ghez, Ph DMD, Julien Lazarovici, MD, Jean-Marie Michot, MD, Valerie Lapierre, PhD MD, Kamelia Alexandrova, Julia Arfi-Rouche, MD, Jean-Henri Bourhis, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4648.
https://doi.org/10.1182/blood.V128.22.4648.4648
Published: 2016